tiprankstipranks
Plus Therapeutics (PSTV)
NASDAQ:PSTV
US Market
PSTV
Plus Therapeutics
RESEARCH TOOLSreports
Want to see PSTV full AI Analyst Report?

Plus Therapeutics (PSTV) Stock News & Sentiment

1,718 Followers
Plus Therapeutics Stockholders Back Directors and Incentive Plan
Premium
Company Announcements
Plus Therapeutics Stockholders Back Directors and Incentive Plan
7d ago
8K
PSTV
Plus Therapeutics Regains Nasdaq Listing Compliance After Reverse Split
Premium
Company Announcements
Plus Therapeutics Regains Nasdaq Listing Compliance After Reverse Split
1M ago
8K
PSTV
PSTV Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
PSTV Upcoming Earnings Report: What to Expect?
1M ago
PSTV
Plus Therapeutics Appoints New Chief Development Officer
Premium
Company Announcements
Plus Therapeutics Appoints New Chief Development Officer
1M ago
8K
PSTV
Plus Therapeutics Gains FDA Orphan Status for REYOBIQ
Premium
Company Announcements
Plus Therapeutics Gains FDA Orphan Status for REYOBIQ
1M ago
8K
PSTV
Plus Therapeutics Enacts Reverse Stock Split to Maintain Listing
Premium
Company Announcements
Plus Therapeutics Enacts Reverse Stock Split to Maintain Listing
2M ago
8K
PSTV
Plus Therapeutics Adds Industry Veteran Ronald Andrews to Board
Premium
Company Announcements
Plus Therapeutics Adds Industry Veteran Ronald Andrews to Board
2M ago
8K
PSTV
More PSTV News >

PSTV News on the Web

Analysts Offer Insights on Healthcare Companies: Plus Therapeutics (PSTV) and Iridex (IRIX)
TipRanks News
Bullish
Analysts’ Top Healthcare Picks: Upstream Bio, Inc. (UPB), Plus Therapeutics (PSTV)
TipRanks News
Neutral
Plus Therapeutics enters pact with Ephemeral for AI execution platform
TipRanks News
Bullish
PSTV Partners with Ephemeral Technologies: AI Platform Set to Accelerate CNS Oncology Precision and Efficiency
Market Chameleon
Neutral
Plus Therapeutics Taps AI Partnership to Advance CNS Oncology Platform—Integration with Ephemeral Targets Precision and Efficiency Gains
Market Chameleon
Neutral
Plus Therapeutics Stockholders Back Directors and Incentive Plan
TipRanks News
Neutral
Plus Therapeutics reports Q1 EPS ($1.05), consensus (87c)
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Plus Therapeutics (PSTV) and Charles River Labs (CRL)
TipRanks News
Neutral

News Score - Last 7 Days

Very Positive
PSTV
Sector Average
Media Buzz
This Week5 articles
Weekly Average2 articles
News Sentiment
This Week100%
Sector Average78%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is PSTV’s Media Buzz Sentiment?
5 articles about PSTV were published this week. In an average week, 2 articles are published.
    What is PSTV’s weekly average amount of articles?
    In an average week, 2 articles about PSTV are published.
      What is PSTV’s News Sentiment?
      100% of articles about PSTV were positive this week, compared to its sector average of 78%.
        Healthcare Stocks that are Trending in the News
        GOSSGossamer Bio
        RLAYRelay Therapeutics
        ROIVRoivant Sciences
        ILAIsland Pharmaceuticals Ltd
        TLSATiziana Life Sciences
        Showing the stocks with the most bullish news sentiment over the past week